Raymond Henderson

535 total citations
14 papers, 339 citations indexed

About

Raymond Henderson is a scholar working on Oncology, Economics and Econometrics and Cancer Research. According to data from OpenAlex, Raymond Henderson has authored 14 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Economics and Econometrics and 3 papers in Cancer Research. Recurrent topics in Raymond Henderson's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Raymond Henderson is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Economic and Financial Impacts of Cancer (3 papers) and Cancer Genomics and Diagnostics (3 papers). Raymond Henderson collaborates with scholars based in United Kingdom, United States and Netherlands. Raymond Henderson's co-authors include Steven Watterson, Victoria McGilligan, Maurice O’Kane, Richard Sullivan, Mark Lawler, Declan French, Tim Maughan, Stephen Palmer, Mark Sculpher and Ethna McFerran and has published in prestigious journals such as Journal of Clinical Oncology, Seminars in Cancer Biology and Health Technology Assessment.

In The Last Decade

Raymond Henderson

12 papers receiving 331 citations

Peers

Raymond Henderson

SURGE

ONCOL

PRM

Solomon Moshkevich United States

Shiying Kong Canada

Bas Peters Netherlands

María Borrell Spain

Brielan Smiechowski Canada

Shanthi Sivendran United States

Sarmad Sadeghi United States

Muriel Licour France

Xiting Cao United States

Gaurav Singal United States

Solomon Moshkevich United States

Raymond Henderson

133 ×1.1

SURGE

136 ×1.9

30 ×0.4

61 ×0.9

ONCOL

71 ×1.3

PRM

Citations per year, relative to Raymond Henderson Raymond Henderson (= 1×) peers Solomon Moshkevich

Countries citing papers authored by Raymond Henderson

Since Specialization

Citations

This map shows the geographic impact of Raymond Henderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raymond Henderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raymond Henderson more than expected).

Fields of papers citing papers by Raymond Henderson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raymond Henderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raymond Henderson. The network helps show where Raymond Henderson may publish in the future.

Co-authorship network of co-authors of Raymond Henderson

This figure shows the co-authorship network connecting the top 25 collaborators of Raymond Henderson. A scholar is included among the top collaborators of Raymond Henderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raymond Henderson. Raymond Henderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Henderson, Raymond, Christopher Sampson, Xavier Pouwels, et al.. (2025). Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report. Value in Health. 28(6). 813–820.

Henderson, Raymond, Declan French, Elaine Stewart, et al.. (2023). Delivering the precision oncology paradigm: reduced R&D costs and greater return on investment through a companion diagnostic informed precision oncology medicines approach. Journal of Pharmaceutical Policy and Practice. 16(1). 84–84. 11 indexed citations

Pouwels, Xavier, Chris Sampson, Renée J.G. Arnold, et al.. (2022). Opportunities and Barriers to the Development and Use of Open Source Health Economic Models: A Survey. Value in Health. 25(4). 473–479. 11 indexed citations

Henderson, Raymond, Declan French, Ethna McFerran, et al.. (2022). Spend less to achieve more: Economic analysis of intermittent versus continuous cetuximab in KRAS wild-type patients with metastatic colorectal cancer. Journal of Cancer Policy. 33. 100342–100342. 2 indexed citations

Normanno, Nicola, Kathi Apostolidis, Francesco De Lorenzo, et al.. (2021). Cancer Biomarkers in the era of precision oncology: Addressing the needs of patients and health systems. Seminars in Cancer Biology. 84. 293–301. 41 indexed citations

Henderson, Raymond, Declan French, Tim Maughan, et al.. (2021). The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study. The Lancet. Gastroenterology & hepatology. 6(9). 709–722. 56 indexed citations

Henderson, Raymond, et al.. (2021). Cost‐effectiveness of precision diagnostic testing for precision medicine approaches against non‐small‐cell lung cancer: A systematic review. Molecular Oncology. 15(10). 2672–2687. 15 indexed citations

Henderson, Raymond, et al.. (2020). Economic burden of not testing for FLT3 to treat acute myeloid leukemia.. Journal of Clinical Oncology. 38(15_suppl). e13652–e13652. 1 indexed citations

Henderson, Raymond, Declan French, Richard Sullivan, et al.. (2019). Molecular biomarkers and precision medicine in colorectal cancer: a systematic review of health economic analysis. Research Portal (Queen's University Belfast). 13 indexed citations

10.

Lawler, Mark, Declan French, Raymond Henderson, Ajay Aggarwal, & Richard Sullivan. (2016). Shooting for the Moon or Flying Too Near the Sun? Crossing the Value Rubicon in Precision Cancer Care. Public Health Genomics. 19(3). 132–136. 5 indexed citations

11.

Henderson, Raymond, Maurice O’Kane, Victoria McGilligan, & Steven Watterson. (2016). The genetics and screening of familial hypercholesterolaemia. Journal of Biomedical Science. 23(1). 39–39. 112 indexed citations

12.

Jones, Lisa, Susan Griffin, Stephen Palmer, et al.. (2004). Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation. Health Technology Assessment. 8(38). iii–iv, 1. 64 indexed citations

13.

Hutton, John, et al.. (2001). PCV9: COST-EFFECTIVENESS OF EPTIFIBATIDE IN THE UK BASED ON PURSUIT TRIAL. Value in Health. 4(6). 491–491. 2 indexed citations

14.

Johnson, Douglas, et al.. (1993). A Prototype Multidisciplinary Cancer Screening Clinic for the Military Medical Facility. Military Medicine. 158(5). 345–347. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact